• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用表观扩散系数鉴别乳腺良性和转移性淋巴结

Differentiation Between Benign and Metastatic Breast Lymph Nodes Using Apparent Diffusion Coefficients.

作者信息

Fardanesh Reza, Thakur Sunitha B, Sevilimedu Varadan, Horvat Joao V, Gullo Roberto Lo, Reiner Jeffrey S, Eskreis-Winkler Sarah, Thakur Nikita, Pinker Katja

机构信息

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

出版信息

Front Oncol. 2022 Feb 23;12:795265. doi: 10.3389/fonc.2022.795265. eCollection 2022.

DOI:10.3389/fonc.2022.795265
PMID:35280791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8905522/
Abstract

The aim of this study was to determine the range of apparent diffusion coefficient (ADC) values for benign axillary lymph nodes in contrast to malignant axillary lymph nodes, and to define the optimal ADC thresholds for three different ADC parameters (minimum, maximum, and mean ADC) in differentiating between benign and malignant lymph nodes. This retrospective study included consecutive patients who underwent breast MRI from January 2017-December 2020. Two-year follow-up breast imaging or histopathology served as the reference standard for axillary lymph node status. Area under the receiver operating characteristic curve (AUC) values for minimum, maximum, and mean ADC (min ADC, max ADC, and mean ADC) for benign malignant axillary lymph nodes were determined using the Wilcoxon rank sum test, and optimal ADC thresholds were determined using Youden's Index. The final study sample consisted of 217 patients (100% female, median age of 52 years (range, 22-81), 110 with benign axillary lymph nodes and 107 with malignant axillary lymph nodes. For benign axillary lymph nodes, ADC values (×10 mm/s) ranged from 0.522-2.712 for mean ADC, 0.774-3.382 for max ADC, and 0.071-2.409 for min ADC; for malignant axillary lymph nodes, ADC values (×10 mm/s) ranged from 0.796-1.080 for mean ADC, 1.168-1.592 for max ADC, and 0.351-0.688 for min ADC for malignant axillary lymph nodes. While there was a statistically difference in all ADC parameters (p<0.001) between benign and malignant axillary lymph nodes, boxplots illustrate overlaps in ADC values, with the least overlap occurring with mean ADC, suggesting that this is the most useful ADC parameter for differentiating between benign and malignant axillary lymph nodes. The mean ADC threshold that resulted in the highest diagnostic accuracy for differentiating between benign and malignant lymph nodes was 1.004×10 mm/s, yielding an accuracy of 75%, sensitivity of 71%, specificity of 79%, positive predictive value of 77%, and negative predictive value of 74%. This mean ADC threshold is lower than the European Society of Breast Imaging (EUSOBI) mean ADC threshold of 1.300×10 mm/s, therefore suggesting that the EUSOBI threshold which was recently recommended for breast tumors should not be extrapolated to evaluate the axillary lymph nodes.

摘要

本研究的目的是确定良性腋窝淋巴结与恶性腋窝淋巴结表观扩散系数(ADC)值的范围,并确定三种不同ADC参数(最小、最大和平均ADC)在区分良性和恶性淋巴结时的最佳ADC阈值。这项回顾性研究纳入了2017年1月至2020年12月期间连续接受乳腺MRI检查的患者。两年的随访乳腺成像或组织病理学检查作为腋窝淋巴结状态的参考标准。使用Wilcoxon秩和检验确定良性和恶性腋窝淋巴结的最小、最大和平均ADC(min ADC、max ADC和mean ADC)的受试者操作特征曲线下面积(AUC)值,并使用约登指数确定最佳ADC阈值。最终的研究样本包括217名患者(100%为女性,中位年龄52岁(范围22 - 81岁)),其中110例腋窝淋巴结为良性,107例腋窝淋巴结为恶性。对于良性腋窝淋巴结,平均ADC的ADC值(×10⁻³mm²/s)范围为0.522 - 2.712,最大ADC为0.774 - 3.382,最小ADC为0.071 - 2.409;对于恶性腋窝淋巴结,平均ADC的ADC值(×10⁻³mm²/s)范围为0.796 - 1.080,最大ADC为1.168 - 1.592,最小ADC为0.351 - 0.688。虽然良性和恶性腋窝淋巴结在所有ADC参数上均存在统计学差异(p<0.001),但箱线图显示ADC值存在重叠,平均ADC的重叠最少,这表明平均ADC是区分良性和恶性腋窝淋巴结最有用的ADC参数。区分良性和恶性淋巴结诊断准确性最高的平均ADC阈值为1.004×10⁻³mm²/s,准确率为75%,灵敏度为71%,特异性为79%,阳性预测值为77%,阴性预测值为74%。这个平均ADC阈值低于欧洲乳腺影像学会(EUSOBI)的平均ADC阈值1.300×10⁻³mm²/s,因此表明最近推荐用于乳腺肿瘤的EUSOBI阈值不应外推用于评估腋窝淋巴结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/354e234f64b2/fonc-12-795265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/69d9be36d560/fonc-12-795265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/a3faed431df7/fonc-12-795265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/136aef11606a/fonc-12-795265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/42b72017eaab/fonc-12-795265-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/354e234f64b2/fonc-12-795265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/69d9be36d560/fonc-12-795265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/a3faed431df7/fonc-12-795265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/136aef11606a/fonc-12-795265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/42b72017eaab/fonc-12-795265-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e0/8905522/354e234f64b2/fonc-12-795265-g005.jpg

相似文献

1
Differentiation Between Benign and Metastatic Breast Lymph Nodes Using Apparent Diffusion Coefficients.利用表观扩散系数鉴别乳腺良性和转移性淋巴结
Front Oncol. 2022 Feb 23;12:795265. doi: 10.3389/fonc.2022.795265. eCollection 2022.
2
Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.扩散加权磁共振成像的作用:预测乳腺癌腋窝淋巴结转移
Acta Radiol. 2014 Oct;55(8):909-16. doi: 10.1177/0284185113509094. Epub 2013 Nov 14.
3
Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Axillary Lymph Nodes in a Sample of Iranian Women with Breast Cancer.扩散加权磁共振成像在评估伊朗乳腺癌女性样本中腋窝转移性淋巴结的诊断价值
Asian Pac J Cancer Prev. 2017 May 1;18(5):1265-1270. doi: 10.22034/APJCP.2017.18.5.1265.
4
Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.采用扩散加权磁共振成像联合常规及动态对比增强磁共振成像评估乳腺癌患者腋窝淋巴结。
Breast Cancer. 2016 May;23(3):525-32. doi: 10.1007/s12282-015-0598-7. Epub 2015 Mar 13.
5
Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.磁共振扩散加权成像的诊断价值:身体不同区域良恶性淋巴结的鉴别
Clin Imaging. 2015 Sep-Oct;39(5):856-62. doi: 10.1016/j.clinimag.2015.05.006. Epub 2015 May 22.
6
Measurement of apparent diffusion coefficient in discrimination of benign and malignant axillary lymph nodes.表观扩散系数测量在鉴别腋窝良恶性淋巴结中的应用
Pol J Radiol. 2019 Dec 22;84:e592-e597. doi: 10.5114/pjr.2019.92315. eCollection 2019.
7
Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.评估磁共振扩散加权成像(DWI)表观扩散系数(ADC)值在胆管癌良恶性淋巴结鉴别诊断中的诊断性能。
Abdom Radiol (NY). 2019 Feb;44(2):473-481. doi: 10.1007/s00261-018-1742-6.
8
Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.腋窝淋巴结与原发肿瘤的表观扩散系数比值在乳腺癌患者淋巴结转移检测中的应用。
J Magn Reson Imaging. 2013 Oct;38(4):824-8. doi: 10.1002/jmri.24031. Epub 2013 Feb 25.
9
Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.在管腔 A 样乳腺癌中,最小表观扩散系数值预测临床阴性腋窝淋巴结转移。
Breast Cancer. 2019 Sep;26(5):628-636. doi: 10.1007/s12282-019-00969-0. Epub 2019 Apr 1.
10
Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Neck Lymph Nodes in Head and Neck Cancer: A Sample of Iranian Patient.扩散加权磁共振成像在评估头颈癌颈部转移性淋巴结中的诊断价值:以伊朗患者为例
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1789-1795. doi: 10.31557/APJCP.2019.20.6.1789.

引用本文的文献

1
Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on Ga-DOTATATE PET/MR.基于 Ga-DOTATATE PET/MR 对神经内分泌肿瘤患者 SSTR-RADS-3A 和 SSTR-RADS-3B 病变的预后预测。
J Cancer Res Clin Oncol. 2024 May 25;150(5):272. doi: 10.1007/s00432-024-05776-5.
2
Axillary Lymphadenopathy after COVID-19 Vaccination: Follow-up for Enlarged Lymph Nodes on MR Imaging.新冠病毒疫苗接种后的腋窝淋巴结病:磁共振成像对肿大淋巴结的随访
Magn Reson Med Sci. 2025 Apr 1;24(2):176-183. doi: 10.2463/mrms.mp.2023-0147. Epub 2024 May 29.
3
Quantitative evaluation of diffusion-weighted MRI for differentiating benign and malignant thyroid nodules larger than 4 cm.

本文引用的文献

1
High-Spatial-Resolution Multishot Multiplexed Sensitivity-encoding Diffusion-weighted Imaging for Improved Quality of Breast Images and Differentiation of Breast Lesions: A Feasibility Study.高空间分辨率多发多通道敏感编码扩散加权成像改善乳腺图像质量和鉴别乳腺病变的可行性研究。
Radiol Imaging Cancer. 2020 May 29;2(3):e190076. doi: 10.1148/rycan.2020190076. eCollection 2020 May.
2
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.美国免疫实施咨询委员会对使用 Moderna COVID-19 疫苗的临时建议-2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Jan 1;69(5152):1653-1656. doi: 10.15585/mmwr.mm695152e1.
3
定量评估扩散加权 MRI 对直径大于 4cm 的甲状腺良恶性结节的鉴别诊断价值。
BMC Med Imaging. 2023 Dec 13;23(1):212. doi: 10.1186/s12880-023-01141-z.
4
Update on DWI for Breast Cancer Diagnosis and Treatment Monitoring.乳腺癌诊断和治疗监测的 DWI 更新。
AJR Am J Roentgenol. 2024 Jan;222(1):e2329933. doi: 10.2214/AJR.23.29933. Epub 2023 Oct 18.
5
The road to breast cancer screening with diffusion MRI.通过扩散磁共振成像进行乳腺癌筛查之路。
Front Oncol. 2023 Feb 21;13:993540. doi: 10.3389/fonc.2023.993540. eCollection 2023.
6
Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.接种辉瑞-生物科技和莫德纳 COVID-19 疫苗后的腋窝淋巴结病:MRI 评估。
Radiology. 2023 Jan;306(1):270-278. doi: 10.1148/radiol.220814. Epub 2022 Sep 13.
7
Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging.乳腺癌N分期之外:基于MRI和超声成像的重要性
Cancers (Basel). 2022 Aug 31;14(17):4270. doi: 10.3390/cancers14174270.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.乳腺弥散加权成像的共识和任务声明:来自 EUSOBI 国际乳腺弥散加权成像工作组。
Eur Radiol. 2020 Mar;30(3):1436-1450. doi: 10.1007/s00330-019-06510-3. Epub 2019 Nov 30.
5
Diffusion-weighted MRI for Unenhanced Breast Cancer Screening.弥散加权 MRI 在乳腺癌筛查中的应用。
Radiology. 2019 Dec;293(3):504-520. doi: 10.1148/radiol.2019182789. Epub 2019 Oct 8.
6
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).扩散加权成像在减少乳腺 MRI 引导的不必要活检中的应用:ECOG-ACRIN 癌症研究组(A6702)的一项试验。
Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15.
7
Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.前哨淋巴结活检与延迟腋窝清扫术相比,腋窝清扫术的上肢并发症
ANZ J Surg. 2018 Sep;88(9):917-921. doi: 10.1111/ans.14382. Epub 2018 Feb 2.
8
A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice.欧洲乳腺影像学会关于乳腺 MRI 在临床实践中应用的调查。
Eur Radiol. 2018 May;28(5):1909-1918. doi: 10.1007/s00330-017-5121-4. Epub 2017 Nov 22.
9
Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Axillary Lymph Nodes in a Sample of Iranian Women with Breast Cancer.扩散加权磁共振成像在评估伊朗乳腺癌女性样本中腋窝转移性淋巴结的诊断价值
Asian Pac J Cancer Prev. 2017 May 1;18(5):1265-1270. doi: 10.22034/APJCP.2017.18.5.1265.
10
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary.早期乳腺癌患者前哨淋巴结活检:2016年美国临床肿瘤学会临床实践指南更新摘要
J Oncol Pract. 2017 Mar;13(3):196-198. doi: 10.1200/JOP.2016.019992. Epub 2017 Jan 24.